Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination
Circulation
DECEMBER 17, 2023
Circulation, Volume 148, Issue 25 , Page 2069-2071, December 19, 2023.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Circulation
DECEMBER 17, 2023
Circulation, Volume 148, Issue 25 , Page 2069-2071, December 19, 2023.
American Heart News - Heart News
NOVEMBER 13, 2023
This abstract is simultaneously published with a full manuscript in the AHA’s flagship journal Circulation. Research Highlights: While the overall incidence of sudden cardiac death among National Collegiate Athletic Association athletes decreased over.
Circulation
AUGUST 4, 2024
Circulation, Volume 150, Issue 6 , Page 488-503, August 6, 2024. Despite early evidence of an antiarrhythmic role of n-3 PUFA in the prevention of sudden cardiac death and postoperative and persistent atrial fibrillation (AF), subsequent well-designed randomized trials have largely not shown an antiarrhythmic benefit.
Circulation
NOVEMBER 27, 2024
Circulation, Ahead of Print. BACKGROUND:Declining cardiovascular mortality rates have been well-documented, yet temporal trends of sudden cardiac death (SCD) in young individuals remain unclear.
Circulation: Genomic and Precision Medicine
FEBRUARY 28, 2024
Circulation: Genomic and Precision Medicine, Ahead of Print. Dilated cardiomyopathy (DCM) is a common heart muscle disorder of nonischemic etiology associated with heart failure development and the risk of malignant ventricular arrhythmias and sudden cardiac death.
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page e255-e256, September 17, 2024.
Circulation: Arrhythmia and Electrophysiology
FEBRUARY 10, 2025
Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
Circulation
MARCH 31, 2024
Circulation, Volume 149, Issue 14 , Page 1059-1061, April 2, 2024.
Circulation
NOVEMBER 12, 2023
Circulation, Ahead of Print.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4139536-A4139536, November 12, 2024. Background:Limited data exist on the incidence of severe QT prolongation (SQTP) in patients using antipsychotics or antidepressants and the associated risk of ventricular arrhythmias (VA) and sudden cardiac death (SCD).Aims:This
Circulation: Genomic and Precision Medicine
DECEMBER 7, 2023
Circulation: Genomic and Precision Medicine, Ahead of Print. BACKGROUND:Few clinical data are available onNEXNmutation carriers, and the gene’s involvement in cardiomyopathies or sudden death has not been fully established.
Dr. Smith's ECG Blog
JUNE 23, 2024
They shocked him twice before return of spontaneous circulation. This is a critically important determination because of the 2017 AHA/ACC/HRS Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. When EMS arrived the patient was in ventricular fibrillation.
Circulation: Cardiovascular Imaging
APRIL 10, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. However, a subset of patients may develop arrhythmic complications, including sudden cardiac arrest and sudden cardiac death. Mitral valve prolapse (MVP) affects 2% to 3% of the general population and is typically benign.
Circulation: Arrhythmia and Electrophysiology
FEBRUARY 3, 2025
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Secondary outcomes included trends of sudden cardiac death, appropriate/inappropriate shocks, and ICD-related complications.RESULTS:In total, 234 studies (N=92 500, 514 748 patient-years) met inclusion criteria. Mean age was 46.2 years and 37.49% were women.
BoardVitals - Cardiovascular
MAY 1, 2017
It is crucial for every medical physician to recognize patients who are at risk of sudden cardiac death due to their underlying medical condition. It is crucial for every medical physician to recognize patients who are at risk of sudden cardiac death due to their underlying medical condition. Circulation.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4115652-A4115652, November 12, 2024. Dapagliflozin has demonstrated efficacy in reducing cardiovascular events in T2D patients and in the risk of serious ventricular arrhythmias and sudden cardiac death.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4120434-A4120434, November 12, 2024. Since its identification in 1981 its diagnosis has increased due to the advancements in cardiac imaging. Since its identification in 1981 its diagnosis has increased due to the advancements in cardiac imaging.
All About Cardiovascular System and Disorders
MARCH 29, 2024
And right ventricular hypertrophy and the abnormal architecture of the right ventricle, can predispose to late arrhythmias and sudden cardiac death in repaired tetralogy of Fallot. Post operative arrhythmias, long term arrhythmias, an important cause of sudden cardiac death in repaired tetralogy of Fallot.
Circulation: Genomic and Precision Medicine
NOVEMBER 29, 2024
Circulation: Genomic and Precision Medicine, Volume 17, Issue 6 , Page e004759, December 1, 2024. Emerging gene therapies have the potential to fill this gap.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4124677-A4124677, November 12, 2024. It presents in acute, indeterminate, and chronic phases, with chronic cardiomyopathy being the most severe form, leading to heart failure, arrhythmias, and sudden cardiac death.
Circulation: Cardiovascular Quality & Outcomes
JANUARY 19, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Serum troponins and CK-MB (creatine kinase-MB) are readily detectable and reliable cardiac-specific biomarkers of subclinical myocardial injury. This study explores the roles of cTnI (cardiac troponin I) and CK-MB in hypertrophic cardiomyopathy (HCM).Methods:This
Circulation: Cardiovascular Imaging
JANUARY 7, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:A subset of patients with mitral valve prolapse (MVP), a highly heritable condition, experience sudden cardiac arrest (SCA) or sudden cardiac death (SCD).
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4139677-A4139677, November 12, 2024. Background:Epicardial patch defibrillators (EPDs) were commonly implanted in the 1990s for secondary prevention of sudden cardiac death. Despite being largely obsolete, some EPDs remain in patients and can cause late complications.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4139584-A4139584, November 12, 2024. An external monitor revealed one episode of non-sustained supraventricular tachycardia, otherwise was unremarkable. He experienced worsening symptoms for which emergency department evaluation revealed anterior lead T-wave inversions on EKG.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4112639-A4112639, November 12, 2024. Cardiac Sarcoidosis (CS) is one of the most severe manifestations. CS has a range of clinical syndromes: impaired conduction, arrhythmias, heart failure, and sudden cardiac death.
Circulation: Arrhythmia and Electrophysiology
FEBRUARY 23, 2024
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Commotio cordis, sudden cardiac death (SCD) caused by relatively innocent impact to the chest, is one of the leading causes of SCD in sports.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142952-A4142952, November 12, 2024.
Circulation: Genomic and Precision Medicine
NOVEMBER 28, 2023
Circulation: Genomic and Precision Medicine, Ahead of Print. BACKGROUND:Hypertrophic cardiomyopathy (HCM) is an important cause of sudden cardiac death associated with heterogeneous phenotypes, but there is no systematic framework for classifying morphology or assessing associated risks.
DAIC
JANUARY 23, 2024
Inflammation driven by signaling cytokines, circulating immune cells, adhesion molecules, and oxidized low-density lipoprotein cholesterol (LDL-C) leads to atherosclerotic plaque development, plaque progression, and eventual rupture.14,15 2019 Sep 10;140(11):e649-e650] [published correction appears in Circulation. Circulation.
Circulation
OCTOBER 27, 2023
Circulation, Ahead of Print. The primary end point was AEs, defined as sudden cardiac death, sudden cardiac arrest, appropriate implantable cardioverter defibrillator shock, and arrhythmic syncope. mg/kg per day [interquartile range, 1.7–3.1]) 3.1]) were included.
DAIC
OCTOBER 2, 2024
Journal of the American College of Cardiology and Circulation, 58, e212-260. Risk factors of sudden cardiac death in hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Hong Y, Su WW, Li X. Current Opinion in Cardiology.
DAIC
MAY 9, 2024
New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.
Dr. Smith's ECG Blog
JANUARY 23, 2024
The granulomatous inflammation affects the heart, causing an infiltrative cardiomyopathy The most common manifestations of cardiac sarcoidosis are atrioventricular (AV) block and ventricular tachyarrhythmias (VT). SCD (sudden cardiac death) from sarcoid heart disease is thought to be caused by either from high-grade AV block or VT.
Dr. Smith's ECG Blog
JULY 22, 2023
This discussion comes from this previous post: Hyperthermia and ST Elevation Discussion Brugada Type 1 ECG changes are associated with sudden cardiac death (SCD) and the occurrence of ventricular dysrhythmias. Circulation, 117, 1890–1893. [3]: See more cases of Brugada due to fever here. Heart Rhythm, 13(7): 1515-1520. [2]:
Dr. S. Venkatesan MD
FEBRUARY 20, 2024
Bardy GH, Lee KL, Mark DB, Poole JE, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Circulation. Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator. Reference 1. N Engl J Med. 2005 Jan 20;352(3):225-37.
Dr. S. Venkatesan MD
MARCH 19, 2024
He said a screening test called cardiac-arrhythmic genome analysis is available in certain European centers. The role of the molecular autopsy in sudden cardiac death in young individuals. Circulation. Ref: Isbister, J.C., Semsarian, C. Nat Rev Cardiol 21 , 215–216 (2024). 1978 Aug;58(2):305-14. doi: 10.1161/01.cir.58.2.305.
EMS 12-Lead
APRIL 28, 2022
Circulation, 144; 823-839. [3] Circulation, 59 (3); 459-468. [8] Pleomorphic ventricular tachycardia and risk for sudden cardiac death. Circulation: Arrhythmia and Electrophysiology, 4 ; 2-4. Chapter 10: Recurrent Ventricular Tachycardia (pg. Wolters-Kluwer: Philadelphia, PA. [2] 2] Viskin, S., 8] Liu, E.,
Dr. Smith's ECG Blog
JANUARY 30, 2019
The limb lead abnormalities appear to be part of the Brugada pattern, as described in this article: Inferior and Lateral Electrocardiographic RepolarizationAbnormalities in Brugada Syndrome Discussion Brugada Type 1 ECG changes are associated with sudden cardiac death (SCD) and the occurrence of ventricular dysrhythmias.
Dr. Smith's ECG Blog
NOVEMBER 24, 2017
It has been shown in this study from NEJM 1998 and this from Circulation 1991 that in congenital long QT, for every 10 ms increase in the Bazett corrected QTc, there is an approximate 5% increased risk of Torsade de Pointe (TdP) in the long term.
Circulation
NOVEMBER 12, 2023
Circulation, Ahead of Print. Background:Understanding the incidence, causes, and trends of sudden cardiac death (SCD) among young competitive athletes is critical to inform preventive policies.Methods:This study included National Collegiate Athletic Association athlete deaths during a 20-year time frame (July 1, 2002, through June 30, 2022).
Circulation
DECEMBER 17, 2023
Circulation, Ahead of Print. BACKGROUND:Exercise-induced cardiac remodeling can be profound, resulting in clinical overlap with dilated cardiomyopathy, yet the significance of reduced ejection fraction (EF) in athletes is unclear. During follow-up, no athletes developed symptomatic heart failure or arrhythmias.
Circulation: Arrhythmia and Electrophysiology
FEBRUARY 20, 2025
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Sudden cardiac death is the most common cause of death in childhood hypertrophic cardiomyopathy (HCM). Recently, 2 risk scores have been developed to estimate the 5-year risk of sudden cardiac death.
Dr. Smith's ECG Blog
MARCH 8, 2025
Circulation Research , 114 (12), 18521866. Circulation , 92 (3), 657671. Risk of acute myocardial infarction after the death of a significant person in ones life. Circulation , 125 (3), 491496. Circumstances attending 100 sudden deaths from coronary artery disease with coroners necropsies. link] Bentzon, J.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content